Where a patient lives may affect what kind of treatment they are offered for their CLL or SLL. However, second opinions and learning about one’s cancer diagnosis can help.
Non-small cell lung cancer (NSCLC) survival benefits don’t extend with further immunotherapy treatment. Limiting treatment can also improve quality of life.